William Mina

Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01

Aditya Bardia, Komal Jhaveri, Seock‐Ah Im et al. · Journal of Clinical Oncology · 2024 · 140 citations · Full text

Medicine, Oncology, Pharmacology +17

Treatment with Ruta graveolens 5CH and Rhus toxicodendron 9CH may reduce joint pain and stiffness linked to aromatase inhibitors in women with early breast cancer: results of a pilot observational study

Jean-Claude Karp, Carole Sanchez, Philippe Guilbert et al. · Homeopathy · 2016 · 31 citations

Medicine, Oncology, Pharmacology +11

First-line systemic treatment with palbociclib in women aged ≥70 years presenting with hormone receptor-positive advanced breast cancer: Results from the PALOMAGE program.

Élisabeth Carola, Marina Pulido, Claire Falandry et al. · Journal of Clinical Oncology · 2023 · 22 citations

Medicine, Oncology, Pharmacology +17